Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer

NCT02769832 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer (SCLC)

Interventions

DRUG: Nab-paclitaxel
DRUG: Gemcitabine

Sponsor

Muhammad Furqan

Collaborators

[object Object]